Page last updated: 2024-09-02

tanshinone and Chemical and Drug Induced Liver Injury, Chronic

tanshinone has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jiang, X; Liu, L; Wang, L; Yang, Y; Zhang, X1

Other Studies

1 other study(ies) available for tanshinone and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.
    Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:1

    Topics: Abietanes; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Chemical and Drug Induced Liver Injury, Chronic; Epigenesis, Genetic; Female; HEK293 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Organic Anion Transporters, Sodium-Dependent; Rifampin; Symporters

2020